5 October 2026 – The International Planned Parenthood Federation (IPPF) has today released its latest survey findings from global research with 40 Member Associations. More than half (55%) of those surveyed experienced an HIV commodity stock out in the last 12 months, directly affecting their ability to provide HIV services
At the time of the survey, 40% of Member Associations reported an active product stock out, and 60% had at least one product at low stock levels. Survey findings also pointed to a generalised problem of supply unreliability and fragility, not simply isolated stockouts. HIV rapid diagnostic tests were the most critically affected product category across all respondents. This is particularly concerning amidst rising HIV epidemics around the world, including in countries where the Member Associations surveyed are responding.
An estimated 40.8 million people are living with HIV worldwide, yet the response is being undermined by deep funding gaps, a sharp downturn in external assistance and a fracturing global health architecture. Abrupt shifts in major donor policies, particularly changes to U.S. foreign assistance and uncertainty around the future of PEPFAR, are driving shortages of HIV tests, pre-exposure prophylaxis (PrEP), condoms and antiretroviral therapy in some settings. Meanwhile, under-resourced health systems are struggling with workforce gaps and service disruption.
IPPF’s research also found that:
- 98% of our partners surveyed provide HIV testing and counselling, yet more than half (55%) cannot reliably sustain HIV testing at point of care because of low stocks or stockouts of rapid diagnostic tests.
- 85% receive HIV commodity supplies from their Ministry of Health or government, leaving them with limited alternatives when national or donor-supported supply chains break down.
Lori Miller, HIV Advisor for IPPF, said:
“Our partners already have what it takes to deliver integrated HIV prevention, testing and treatment: the clinic networks, digital infrastructure, health workforce and community trust to reach people with care. We are incredibly proud of them. But unreliable supplies are letting them down.”
IPPF has committed additional funding to support 13 Member Associations facing urgent HIV commodity shortages, prioritizing rapid diagnostic tests and pre-exposure prophylaxis methods. However, a significant funding gap remains to bolster supply levels for all HIV commodities across IPPF's global network.
Mallah Talbot, Senior Technical Advisor, Africa Regional Office, said:
“These shortages are a warning of what happens when funding becomes uncertain and the supply systems communities depend on grow fragile. We cannot let decades of progress against HIV be undone simply because products aren't available. This is not a distant risk. It is already happening: HIV infections are rising in a number of countries around the world, and lives are being lost.”
ENDS
For further information or to arrange media interviews with our spokespeople, please contact Nerida Williams on newilliams@ippf.org.
Notes
- In Quarter 2 of 2026, IPPF’s Harm Mitigation Task Force surveyed 55 of the 102 Member Associations that provide HIV-related services, based on identified and anticipated need.
- 40 Member Associations responded (a 73 per cent response rate). Respondents were from all six of IPPF’s regions, including Africa (18), the Arab World (4), East and Southeast Asia/Oceania (3), Europe (4), Americas and the Caribbean (8, and South Asia (3).
- In 2025, IPPF Member Associations provided 29.8 million HIV/AIDS related services.
when
Subject
HIV
HIV Commodity Supply Under Pressure
